Of note, knockdown of proximal and distal sub-units associated with BCR, of specifically toxic to ABC-DLBCL, contributing to potential to the development of BCR-targeted therapies for ABC-DLBCL subtype [80]. This evidence concerns the gene BCR and diffuse large B-cell lymphoma.